Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial
Top Cited Papers
Open Access
- 11 December 2009
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 374 (9707) , 2055-2063
- https://doi.org/10.1016/s0140-6736(09)61523-3
Abstract
No abstract availableFunding Information
- Southwest Oncology Group ((SWOG)-8814, INT-0100)
- National Cancer Institute, Department of Health and Human Services (CA38926, CA32102, CA21115, CA02599, CA60138, CA25224, CA77202-06, CA04920, CA58658, CA13612, CA37981, CA76447, CA22433, CA58416, CA20319, CA58686, CA04919, CA46441, CA58861, CA27057, CA32734, CA35281, CA12644, CA16385, CA45560, CA58882, CA14028, CA35176, CA46282, CA46113, CA52650, CA03096, CA28862, CA35090, CA58723, CA35283, CA45807, CA35200, CA35119, CA45450, CA46136, CA42777, CA35261, CA45466, CA35117, CA46368, CA58348, CA12213, CA52654, CA35128, CA58415, CA52623, CA35192, CA45377, CA35996, CA52757, CA76132, CA35431, CA76462, CA45461, CA35084, CA76429, CA35178, CA67663, CA63844, CA52772)
This publication has 31 references indexed in Scilit:
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trialThe Lancet Oncology, 2010
- Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005Annals of Oncology, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Endocrine Responsiveness and Tailoring Adjuvant Therapy for Postmenopausal Lymph Node-Negative Breast Cancer: A Randomized TrialJNCI Journal of the National Cancer Institute, 2002
- National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000JNCI Journal of the National Cancer Institute, 2001
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Anatagonism of the cytocidal activity and uptake of melphalan by tamoxifen in human breast cancer cells in vitroBiochemical Pharmacology, 1985
- Designs for group sequential testsControlled Clinical Trials, 1984
- Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycleEuropean Journal of Cancer and Clinical Oncology, 1983
- Combined chemo-hormonal therapy in breast cancer: A hypothesisBreast Cancer Research and Treatment, 1981